Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Molecular Immunology|August 14, 2018
MicroRNA regulation of natural killer cell development and function in leukemiaJennifer N Saultz, Aharon G Freud, Bethany L Mundy-BosseImmunity|November 23, 2017
The Broad Spectrum of Human Natural Killer Cell DiversityAharon G Freud, Bethany L Mundy-Bosse, Jianhua Yu, et al.Journal of Leukocyte Biology|March 2, 2023
Effects of epigenetic therapy on natural killer cell function and development in hematologic malignancyMatthew R Lordo, Andrew R Stiff, Christopher C Oakes, et al.Cellular Immunology|May 24, 2011
Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patientsBethany L Mundy-Bosse, Lisa M Thornton, Hae-Chung Yang, et al.Cancers|January 22, 2021
Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid LeukemiaMatthew R Lordo, Steven D Scoville, Akul Goel, et al.Leukemia & Lymphoma|July 7, 2021
Functional expression of aryl hydrocarbon receptor as a potential novel therapeutic target in human multiple myelomaTiffany Hughes, Francesca Cottini, Evan Catton, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2011
Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cellsKristan D Guenterberg, Gregory B Lesinski, Bethany L Mundy-Bosse, et al.Cancers|February 11, 2023
Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell MetabolismMarcelo S F Pereira, Kinnari Sorathia, Yasemin Sezgin, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2011
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancyBethany L Mundy-Bosse, Gregory S Young, Todd Bauer, et al.Nature Immunology|April 29, 2022
ILC1s control leukemia stem cell fate and limit development of AMLZhenlong Li, Rui Ma, Shoubao Ma, et al.Pageof 7